Retigabine (Ezogabine) 100mg 100mg | Purity Not Available
Adooq Bioscience
Retigabine is an anticonvulsant used as a treatment for partial epilepsies.
More Information Supplier PageSearch Results
Roxatidine acetate hydrochloride 500mg 500mg | Purity Not Available
Adooq Bioscience
Roxatidine Acetate Hydrochloride is a histamine H2-receptor antagonist used in ulcer treatment. This compound has been found to inhibit platelet function in vitro.
More Information Supplier PageRoxatidine acetate hydrochloride 250mg 250mg | Purity Not Available
Adooq Bioscience
Roxatidine Acetate Hydrochloride is a histamine H2-receptor antagonist used in ulcer treatment. This compound has been found to inhibit platelet function in vitro.
More Information Supplier PageRoxatidine acetate HCl 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Roxatidine Acetate Hydrochloride is a histamine H2-receptor antagonist used in ulcer treatment. This compound has been found to inhibit platelet function in vitro.
More Information Supplier PageRoxatidine acetate hydrochloride 1000mg 1000mg | Purity Not Available
Adooq Bioscience
Roxatidine Acetate Hydrochloride is a histamine H2-receptor antagonist used in ulcer treatment. This compound has been found to inhibit platelet function in vitro.
More Information Supplier PageRoxatidine acetate hydrochloride 100mg 100mg | Purity Not Available
Adooq Bioscience
Roxatidine Acetate Hydrochloride is a histamine H2-receptor antagonist used in ulcer treatment. This compound has been found to inhibit platelet function in vitro.
More Information Supplier PageARN-509 10mg 10mg | Purity Not Available
Adooq Bioscience
ARN-509 is an androgen receptor antagonist with potential antineoplastic activity. ARN-509 binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus. This prevents binding to and transcription of AR-responsive genes.
More Information Supplier PageARN-509 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
ARN-509 is an androgen receptor antagonist with potential antineoplastic activity. ARN-509 binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus. This prevents binding to and transcription of AR-responsive genes.
More Information Supplier Page